Skip to content
Back to Investors
Kindred

Kindred

Venture Capital

Kindred is an early stage venture capital firm that backed Lottie in its seed round.

Portfolio

19

companies

Investment by month

By category

  • eCommerce£184M
  • AI/ML£100M
  • FinTech£33.5M
  • Robotics£30.4M
  • BioTech£30.2M
  • Other£111M

By location

  • London£437M
  • San Francisco£40.0M
  • Cambridge£12.5M

Portfolio companies

Acurable

Acurable

Acurable develops wearable medical devices that automate the diagnosis of respiratory conditions at home.

B

BotsAndUs

BotsAndUs builds autonomous mobile robots and AI software to automate warehouse logistics.

C

Clove

Clove builds a hybrid financial advice platform powered by human expertise and artificial intelligence.

Dexory

Dexory

Dexory provides autonomous robotics and data intelligence platforms for warehouse operations.

Disperse

Disperse

Building productivity systems for the construction sector.

F

Farewill

Farewill modernises the death and bereavement sector with digital wills, probate, and funerals.

View all 19 companies

Team

CC

Chrys Chrysanthou

LinkedIn
Russell Buckley

Russell Buckley

Partner

Russell brings venture capital and chairmanship experience from roles at Kindred Capital, Ballpark Ventures, and Adzact.

LinkedIn
CC

Chrysanthos Chrysanthou

Maria Palma

Maria Palma

General Partner

Maria is a general partner at Kindred and Freestyle Capital, alongside investor roles at various companies.

LinkedIn
John Cassidy

John Cassidy

Partner

John is a general partner at Kindred Capital and a board member at Fractile and Latent Labs. He previously served as general manager for genomics at Dante Labs and founded CCG.ai.

LinkedIn

Recent investments

Series A
£40.0M

The financing round was co-led by Radical Ventures and Sofinnova Partners to accelerate the development of programmable biology tools.

"Every biotechnology or pharmaceutical company wants to be at the forefront of technology to find the best therapeutic molecules, yet not all are in a position to develop the most advanced AI models for the job. That’s where Latent Labs comes in. We push the frontiers of generative biology, giving our partners instant access to tools that accelerate their drug design programs."
— Simon Kohl, CEO and founder
Seed
£12.0M

The seed round was co-led by Kindred Capital, NATO Innovation Fund, and Oxford Science Enterprises.

"In today’s AI race, the limitations of existing hardware – nearly all of which is provided by a single company – represent the biggest barrier to better performance, reduced cost, and wider adoption. Fractile’s approach supercharges inference, delivering astonishing improvements in terms of speed and cost. This is more than just a speed-up – changing the performance point for inference allows us to explore completely new ways to use today’s leading AI models to solve the world’s most complex problems. We’re thrilled to have raised our funding from investors with a wealth of experience in the AI and chip industries, continue to grow our world-class team and further our technological development and partnerships."
— Walter Goodwin, Researcher
Series A
£15.0M

Atomico led the Series A round with participation from existing investors including Lakestar, Kindred, and Maersk Growth.

"For those operating warehouses, ensuring 100% fulfilment ‘in time, all the time’ is crucial to meeting the demands of the modern consumer. A critical component to achieving this is high stock accuracy, but staff shortages, manual processes, and the speed demanded by customers means that critical decisions across the supply chain are currently being taken blindly,"
— Andrei Danescu